News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Arteriocyte, Inc. Wins $4.99 Million in Grant Money



5/1/2009 8:12:22 AM

Bookmark and Share

Private Equity Hub -- Arteriocyte, a commercial stage biotechnology company based in Cleveland, Ohio, has recieved $4.99 million from Ohio Third Frontier Commission’s Research Commercialization Program to expand clinical applications for its products. The company has received venture backing from DW Healthcare Partners.




comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES